In Situ Targeting RGD-Modified Cyclodextrin Inclusion Complex/Hydrogel Hybrid System for Enhanced Glioblastoma Therapy

<b>Background/Objectives</b>: Glioblastoma (GBM) remains the most aggressive primary brain tumor, characterized by high malignancy, recurrence rate, and dismal prognosis, thereby demanding innovative therapeutic strategies. In this study, we report a novel in situ targeting inclusion com...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Xiaofeng Yuan, Zhenhua Wang, Pengcheng Qiu, Zhenhua Tong, Bingwen Wang, Yingjian Sun, Xue Sun, Lu Sui, Haiqiang Jia, Jiajun Wang, Haifeng Tang, Weiliang Ye
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Subjects:	doxorubicin cyclodextrin inclusion complex hydrogel glioblastoma
Online Access:	https://www.mdpi.com/1999-4923/17/7/938